ahlam1399
08-06-2015, 07:00 PM
BRIEF-Allergan says experimental anti-depressant would serve ?huge? market
* Allergan CEO, in conference call with analysts, says company will remain more of a "virtual" research company, relying mainly on licensing deals or acquisitions
http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/a2.img (http://da.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/ach.img (http://adchoice.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/ach.htm)http://pi.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/48c344b7/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=4Lr0miXKLH8:lHblnjcclBw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=4Lr0miXKLH8:lHblnjcclBw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=4Lr0miXKLH8:lHblnjcclBw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=4Lr0miXKLH8:lHblnjcclBw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=4Lr0miXKLH8:lHblnjcclBw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/4Lr0miXKLH8
* Allergan CEO, in conference call with analysts, says company will remain more of a "virtual" research company, relying mainly on licensing deals or acquisitions
http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/a2.img (http://da.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/ach.img (http://adchoice.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/ach.htm)http://pi.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/a2t.imghttp://pi2.feedsportal.com/r/234566793172/u/49/f/654213/c/35217/s/48c344b7/sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/48c344b7/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=4Lr0miXKLH8:lHblnjcclBw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=4Lr0miXKLH8:lHblnjcclBw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=4Lr0miXKLH8:lHblnjcclBw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=4Lr0miXKLH8:lHblnjcclBw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=4Lr0miXKLH8:lHblnjcclBw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/4Lr0miXKLH8